by MASA | Apr 23, 2024 | Drug Updates, News
The U.S. Food and Drug Administration (FDA) has provided an emergency use authorization (EUA) for a new medicine called Pemgarda™ (pemivibart), aimed at preventing COVID-19 in certain high-risk individuals. This medication is specifically designed for those who are...
by MASA | Mar 31, 2024 | Drug Updates
US FDA approved of XHANCE as the first and only medication for adults with chronic rhinosinusitis without nasal polyps. It is a fluticasone propionate nasal spray which uses the Exhalation Delivery System to enable topical steroid to the inflamed areas and is proven...
by MASA | Mar 11, 2024 | Allergies, Anaphylaxis, Asthma
Central Illinois School Asthma and Allergy Resources for Students Welcome to the Central Illinois School Health Resources page! This page aims to unify and provide essential information and resources for schools and school nurses to promote student health and safety...
by MASA | Feb 26, 2024 | Allergies, Food Allergies / Intolerance
(Enrollment Closed) Join Our Groundbreaking Peanut Allergy Clinical Trial for Children in Bloomington/Normal, IL We’re excited to announce our call for participants in the VITESSE (DBV) clinical trial, a new study focused on innovative treatments for peanut...
by MASA | Jan 31, 2024 | Immunodeficiency Hypogammaglobulinemia, Rare Diseases
What is PIDD? What is PIDD? PIDD stands for Primary Immunodeficiency Diseases. These diseases are a group of more than 500 rare, chronic disorders in which part of the body’s immune system is missing or functions improperly. Because the immune system is...
